Edogestrone
- Level
- Commodity
- Parent
- 51351500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351504This classification denotes a therapeutic progestin with the molecular formula C26H38O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9014UFK50C, chemically known as 17-hydroxy-6-methylpregn-5-ene-3,20-dione cyclic 3-(ethylene acetal) acetate but generally known as edogestrone, which bears US NIH Compound Identifier 101860. European Medicines Agency schedules Edogestrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06459MIG. The term EDOGESTRONE is an International Non-Proprietary Name. EDOGESTRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule edogestrone under HS 29372300 and SITC 54153. As of Q4 2014, EDOGESTRONE remains the US FDA Preferred Term for this commodity. Edogestrone bears US NLM identifiers UMLS ID C0603207 and NCI Concept Code C74368. SMILES: O(C1(C2(C(C3C(C4(C(=C(C3)C)CC3(OCCO3)CC4)C)CC2)CC1)C)C(=O)C)C(=O)C.
Same parent
Under 51351500 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.